{"results": [{"id": "0001270073:2012:FY", "start_date": "2012-01-01", "end_date": "2012-12-31", "filing_date": "2013-04-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2012", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-13-019166", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-13-019166/files/icpt-20121231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -43643071.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -43643071.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -43480022.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 21359693.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -43643071.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -18913588.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -43643071.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -43643071.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 2446105.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -18913588.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 21359693.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -46273506.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 2630435.0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 2630435.0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 21359693.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "nonoperating_income_loss": {"value": -24729483.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}, "balance_sheet": {"liabilities": {"value": 46266732.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 148838, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_liabilities": {"value": 12964054.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 33302678.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 111778219.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 65911865.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 112178597.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 400378, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 112178597.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 65911865.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_than_fixed_noncurrent_assets": {"value": 251540, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 108418234.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 27804165.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -15749468.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 108418234.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": -7233, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": 27811398.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -64857368.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -15749468.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -64857368.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"id": "0001270073:2013:FY", "start_date": "2013-01-01", "end_date": "2013-12-31", "filing_date": "2014-03-14", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2013", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-14-015854", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-14-015854/files/ipct-20131231.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 82406100.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 67912480.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 150318580.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 82406100.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 147564538.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 8881427.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 2754042.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 150318580.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 1672295.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_liabilities": {"value": 59031053.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 1081747.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -67792410.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -67792410.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -67711107.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -67792410.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "nonoperating_income_loss": {"value": -28340691.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_income_loss": {"value": -39451719.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -67792410.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 41073346.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -39451719.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -67792410.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 41073346.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 41073346.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 1621627.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -67792410.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -28006409.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": 0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": -70213569.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -28006409.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 66071523.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -32148456.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 66071523.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -70213569.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -32148456.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"id": "0001270073:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-02", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-15-013338", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-15-013338/files/icpt-20141231.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -283569642.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -283226000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -283226000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"assets": {"value": 254148933.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 254148933.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 245827834.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 230890523.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 230890523.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 8017301.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 23258410.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 8321099.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 15241109.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 2469343.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "fixed_assets": {"value": 5851756.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 190983262.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 6659742.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 190983262.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -96585176.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -87738344.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -96585176.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -87738344.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 6659742.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"revenues": {"value": 1741618.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 114911832.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -283225954.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -113170214.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -13.82, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -113170214.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -283225954.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -283225954.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -283225954.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": -170055740.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 114911832.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 114911832.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -13.82, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"id": "0001270073:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-02-29", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-16-085037", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-16-085037/files/icpt-20151231.xml", "financials": {"income_statement": {"net_income_loss": {"value": -226429000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 2782000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": 2727000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -226429000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -229156000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 231938000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 231938000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -226429000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -226429000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -226429000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 229211000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -226429000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "balance_sheet": {"assets": {"value": 655758000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 4018000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 641693000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 14065000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 602149000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 47373000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 6236000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 53609000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 655758000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 10047000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_parent": {"value": 602149000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow": {"value": 12719000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 565469000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -162902000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 13095000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 565469000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -389472000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -376000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -162902000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -389472000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -226429000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -228401000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -227648158.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"id": "0001270073:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-03-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-17-012180", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-17-012180/files/icpt-20161231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 414382000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": -873000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 414382000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 10933000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -60135000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -342441000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 11806000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -342441000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -60135000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -412830000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -413501000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -413378000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -412830000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -412830000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 437781000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -412830000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -402538000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -412830000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 437781000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "nonoperating_income_loss": {"value": -10292000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 24951000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_before_equity_method_investments": {"value": -412830000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "interest_expense_operating": {"value": 14196000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -412830000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 427489000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"noncurrent_liabilities": {"value": 345809000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 314932000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 314932000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 11295000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 424321000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 31388000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 78512000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 739253000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 707865000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 739253000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 20093000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}}}, {"id": "0001270073:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-18-011793", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-18-011793/files/icpt-20171231.xml", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -360367000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_before_equity_method_investments": {"value": -360367000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "revenues": {"value": 130956000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -360367000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "gross_profit": {"value": 129585000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "interest_expense_operating": {"value": 29271000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "nonoperating_income_loss": {"value": -24755000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 466568000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -360367000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -360367000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -335612000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -360367000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "cost_of_revenue": {"value": 1371000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 491323000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 491323000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -360367000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -360367000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -358351000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow": {"value": 26338000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": 1127000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -265402000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 25211000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 2838000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 287775000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 2838000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 287775000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -265402000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"equity": {"value": 16386000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 363927000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 104034000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 36040000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 484347000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 467961000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_than_fixed_noncurrent_assets": {"value": 19856000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": 16386000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 16184000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 448307000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 484347000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"id": "0001270073:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-03-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001144204-19-011650", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001144204-19-011650/files/icpt-20181231.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 509167000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 16331000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 482425000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 114205000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 375832000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 509167000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 26742000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 19130000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 10411000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 19130000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 490037000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -310715000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -1473000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -310715000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"gross_profit": {"value": 177285000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -309242000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 489046000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -285490000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "cost_of_revenue": {"value": 2519000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -309242000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -309242000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 30523000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -309242000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -309242000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": -23752000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 489046000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 465294000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 179804000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_before_equity_method_investments": {"value": -309242000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "cash_flow_statement": {"exchange_gains_losses": {"value": -1526000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": -25239000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -240714000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -48070000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 263545000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -26765000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 263545000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -48070000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -240714000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"id": "0001270073:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-02-25", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-20-001314", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-20-001314/files/icpt-20191231x10k93558c_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 1122000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -343559000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -343559000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 51556000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 33571000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 721315000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 541325000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 754886000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 5202000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 51556000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 754886000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 28369000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities": {"value": 703330000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 162005000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"net_income_loss": {"value": -344681000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 596683000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_before_equity_method_investments": {"value": -344681000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "cost_of_revenue": {"value": 4212000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "revenues": {"value": 252002000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 564429000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "gross_profit": {"value": 247790000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 560217000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -344681000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_expense_operating": {"value": 41144000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -312427000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -344681000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -344681000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": -32254000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -344681000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"exchange_gains_losses": {"value": -386000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 457519000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -188988000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -188988000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -236613000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 31532000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -236613000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 457519000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 31918000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"id": "0001270073:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-02-25", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-001804", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-001804/files/icpt-20201231x10k_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -170026000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -7902000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -9126000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 162817000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -1224000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": -693000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -693000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -170026000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 162817000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -276213000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -276213000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -1333000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"fixed_assets": {"value": 6326000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 34748000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 545741000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 179076000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 580489000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": -166853000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 580489000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 28422000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": -166853000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 568266000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 747342000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"gross_profit": {"value": 307368000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_continuing_operations_after_tax": {"value": -274880000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 543930000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_before_equity_method_investments": {"value": -274880000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "cost_of_revenue": {"value": 5322000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -274880000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -231240000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -274880000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -274880000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -274880000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_expense_operating": {"value": 48054000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 587570000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": -43640000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 538608000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 312690000.0, "unit": "USD", "label": "Revenues", "order": 100}}}}, {"id": "0001270073:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-03-02", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001270073", "sic": "2834", "tickers": ["ICPT"], "company_name": "INTERCEPT PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-002666", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-002666/files/icpt-20211231x10k_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 30205000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 1118000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 28755000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1118000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -41639000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -41639000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 70726000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 70726000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -1450000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -91426000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 419141000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 54419000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "cost_of_revenue": {"value": 3100000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 454894000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 416041000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -91426000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -55673000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -91426000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -91426000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -2.87, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": -35753000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -2.87, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 363468000.0, "unit": "USD", "label": "Revenues", "order": 100}, "gross_profit": {"value": 360368000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_continuing_operations_after_tax": {"value": -91426000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"assets": {"value": 527023000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": -183962000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 544168000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 527023000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 24731000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 710985000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 3377000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "other_than_fixed_noncurrent_assets": {"value": 21354000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_liabilities": {"value": 166817000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -183962000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 502292000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -396000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -91822000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -91822000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}], "status": "OK", "request_id": "a99f5492a6e10564aef9fde05e751f7d"}